This fusion protein exerted excellent hepatoprotective and antifibrotic effects in chronic hepatitis model mice by improving the bioavailability of type-I IFN in Kupffer cells as a result of the high-mannose chains of mannosylated albumin being recognized by the macrophage mannose receptor. Here, ALB is linked to chronic hepatitis.